| A clinical trial to maintain glycemic control in youth with type 2 diabetes TODAY Study Group New England Journal of Medicine 366 (24), 2247-2256, 2012 | 960 | 2012 |
| Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation D Lowance, HH Neumayer, CM Legendre, JP Squifflet, J Kovarik, ... New England Journal of Medicine 340 (19), 1462-1470, 1999 | 845 | 1999 |
| RESULTS OF THE DOUBLE-BLIND, RANDOMIZED, MULTICENTER, PHASE III CLINICAL TRIAL OF THYMOGLOBULIN VERSUS ATGAM IN THE TREATMENT OF ACUTE GRAFT REJECTION EPISODES AFTER RENAL … AO Gaber, MR First, RJ Tesi, RS Gaston, R Mendez, LL Mulloy, JA Light, ... Transplantation 66 (1), 29-37, 1998 | 340 | 1998 |
| Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin DJ Norman, DR Illingworth, J Munson, J Hosenpud New England Journal of Medicine 318 (1), 46-47, 1988 | 325 | 1988 |
| The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors WJ Burlingham, AP Grailer, DM Heisey, FHJ Claas, D Norman, ... New England Journal of Medicine 339 (23), 1657-1664, 1998 | 314 | 1998 |
| Action and toxicity of cyclosporine WM Bennett, DJ Norman Annual review of medicine 37 (1), 215-224, 1986 | 234 | 1986 |
| A randomized clinical trial of induction therapy with OKT3 in kidney transplantation DJ Norman, L Kahana, FP STUART JR, JR THISTLETHWAITE JR, ... Transplantation 55 (1), 44-50, 1993 | 185 | 1993 |
| Postrenal transplant erythrocytosis: a review of 53 patients CG Wickre, DJ Norman, A Bennison, JM Barry, WM Bennett Kidney International 23 (5), 731-737, 1983 | 180 | 1983 |
| Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors AM De Mattos, J Prather, AJ Olyaei, Y Shibagaki, DS Keith, M Mori, ... Kidney international 70 (4), 757-764, 2006 | 173 | 2006 |
| Conversion of stable kidney transplant recipients from a twice daily Prograf based regimen to a once daily modified release tacrolimus based regimen R Alloway, Tacrolimus Modified Release Kidney Conversion Study Group Transplantation 78 (2), 142, 2004 | 166 | 2004 |
| OKT3 monoclonal antibody plasma levels during therapy and the subsequent development of host antibodies to OKT3 G Goldstein, AJ Fuccello, DJ Norman, CF Shield III, RB Colvin, AB Cosimi Transplantation 42 (5), 507-510, 1986 | 156 | 1986 |
| Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. AA Oni, RE Hershberger, DJ Norman, J Ray, H Hovaguimian, ... The Journal of heart and lung transplantation: the official publication of …, 1992 | 142 | 1992 |
| The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol M Thorp, A DeMattos, W Bennett, J Barry, D Norman Transplantation 69 (6), 1218-1221, 2000 | 137 | 2000 |
| Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. JP Everett, RE Hershberger, DJ Norman, S Chou, RM Ratkovec, ... The Journal of Heart and Lung Transplantation: the Official Publication of …, 1992 | 137 | 1992 |
| Renal transplantation across the ABO barrier using A2 kidneys AM Alkhunaizi, AM De Mattos, JM Barry, WM Bennett, DJ Norman Transplantation 67 (10), 1319-1324, 1999 | 125 | 1999 |
| Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation AM De Mattos, AJ Olyaei, JC Prather, MS Golconda, JM Barry, DJ Norman Kidney international 67 (2), 714-720, 2005 | 122 | 2005 |
| Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease H Payami, GD Schellenberg, S Zareparsi, J Kaye, GJ Sexton, MA Head, ... Neurology 49 (2), 512-518, 1997 | 110 | 1997 |
| Mechanisms of action and overview of OKT3 DJ Norman Therapeutic drug monitoring 17 (6), 615-620, 1995 | 110 | 1995 |
| Prospective risk stratification in renal transplant candidates for cardiac death A Le, R Wilson, K Douek, L Pulliam, D Tolzman, D Norman, J Barry, ... American journal of kidney diseases 24 (1), 65-71, 1994 | 105 | 1994 |
| Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics MD Pescovitz, D Conti, J Dunn, T Gonwa, P Halloran, H Sollinger, ... Clinical transplantation 14 (3), 179-188, 2000 | 104 | 2000 |
